Works matching IS 00912700 AND DT 2016 AND VI 56 AND IP 5

Results: 18

Issue Information.

Published in:: Journal of Clinical Pharmacology, 2016, v. 56, n. 5, p. 511, doi. 10.1002/jcph.747
Publication type:: Article

Enhanced elimination of dabigatran: Identifying the appropriate patient for the use of continuous venovenous hemodialysis instead of intermittent hemodialysis-A simulation analysis.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 5, p. 597, doi. 10.1002/jcph.620

By:

Liesenfeld, Karl‐Heinz;
Gruenenfelder, Fredrik;
Clemens, Andreas

Publication type:

Article

Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 5, p. 628, doi. 10.1002/jcph.628

By:

Wang, Xiaoli;
Tirucherai, Giridhar;
Marbury, Thomas C.;
Wang, Jessie;
Chang, Ming;
Zhang, Donglu;
Song, Yan;
Pursley, Janice;
Boyd, Rebecca A.;
Frost, Charles

Publication type:

Article

Biomarker exposure-response relationships as the basis for rational dose selection: Lessons from a simulation exercise using a selective COX-2 inhibitor.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 5, p. 609, doi. 10.1002/jcph.629

By:

Taneja, Amit;
Oosterholt, Sean P.;
Danhof, Meindert;
Della Pasqua, Oscar

Publication type:

Article

Population Pharmacokinetics of Rifampicin in Chinese Patients With Pulmonary Tuberculosis.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 5, p. 622, doi. 10.1002/jcph.643

By:

Jing, Ying;
Zhu, Li Qin;
Yang, Jian Wei;
Huang, Shu Ping;
Wang, Qian;
Zhang, Jie

Publication type:

Article

Are We Getting the Best Return on Investment From Clinical Drug-Drug Interaction Studies?

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 5, p. 555, doi. 10.1002/jcph.661

By:

Lesko, Lawrence J.;
Lagishetty, Chakradhar V.

Publication type:

Article

Exploratory effects of a strong CYP3A inhibitor (ketoconazole), a strong CYP3A inducer (rifampicin), and concomitant ethanol on piragliatin pharmacokinetics and pharmacodynamics in type 2 diabetic patients.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 5, p. 548, doi. 10.1002/jcph.617

By:

Zhi, Jianguo;
Zhai, Suoping;
Georgy, Angela;
Liang, Zhenming;
Boldrin, Mark

Publication type:

Article

Absolute bioavailability and pharmacokinetics of the angiotensin II receptor antagonist fimasartan in healthy subjects.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 5, p. 576, doi. 10.1002/jcph.618

By:

Ghim, Jong‐Lyul;
Paik, Soo Heui;
Hasanuzzaman, M.;
Chi, Yong Ha;
Choi, Hyang‐Ki;
Kim, Dong‐Hyun;
Shin, Jae‐Gook

Publication type:

Article

Ocular pharmacology.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 5, p. 517, doi. 10.1002/jcph.634

By:

Novack, Gary D.;
Robin, Alan L.

Publication type:

Article

Design Features of Drug-Drug Interaction Trials Between Antivirals and Oral Contraceptives.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 5, p. 541, doi. 10.1002/jcph.637

By:

Ayala, Ruben C.;
Arya, Vikram;
Younis, Islam R.

Publication type:

Article

Effects of meal type on the oral bioavailability of the ALK inhibitor ceritinib in healthy adult subjects.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 5, p. 559, doi. 10.1002/jcph.619

By:

Lau, Yvonne Y.;
Gu, Wen;
Lin, Tiffany;
Song, Dongweon;
Yu, Richard;
Scott, Jeffrey W.

Publication type:

Article

Pharmacokinetics of metoprolol during pregnancy and lactation.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 5, p. 581, doi. 10.1002/jcph.631

By:

Ryu, Rachel J.;
Eyal, Sara;
Easterling, Thomas R.;
Caritis, Steve N.;
Venkataraman, Raman;
Hankins, Gary;
Rytting, Erik;
Thummel, Kenneth;
Kelly, Edward J.;
Risler, Linda;
Phillips, Brian;
Honaker, Matthew T.;
Shen, Danny D.;
Hebert, Mary F.

Publication type:

Article

Pregnancy-induced changes in the pharmacokinetics of caffeine and its metabolites.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 5, p. 590, doi. 10.1002/jcph.632

By:

Yu, Tian;
Campbell, Sarah C.;
Stockmann, Chris;
Tak, Casey;
Schoen, Katherine;
Clark, Erin A. S.;
Varner, Michael W.;
Spigarelli, Michael G.;
Sherwin, Catherine M. T.

Publication type:

Article

Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 5, p. 637, doi. 10.1002/jcph.633

By:

Chang, Ming;
Yu, Zhigang;
Shenker, Andrew;
Wang, Jessie;
Pursley, Janice;
Byon, Wonkyung;
Boyd, Rebecca A.;
LaCreta, Frank;
Frost, Charles E.

Publication type:

Article

Response to Letter to the Editor From Drs. Stöllberger and Finsterer.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 5, p. 648, doi. 10.1002/jcph.687

By:

Frost, Charles;
Chang, Ming;
Yu, Zhigang;
Shenker, Andrew;
Wang, Jessie;
Pursley, Janice;
Byon, Wonkyung;
Boyd, Rebecca A.;
LaCreta, Frank

Publication type:

Article

Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 5, p. 567, doi. 10.1002/jcph.630

By:

Godoy, Ana Leonor Pardo Campos;
Rocha, Adriana;
da Silva Souza, Cacilda;
Lanchote, Vera Lucia

Publication type:

Article

Renal Function Descriptors in Neonates: Which Creatinine-Based Formula Best Describes Vancomycin Clearance?

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 5, p. 528, doi. 10.1002/jcph.650

By:

Bhongsatiern, Jiraganya;
Stockmann, Chris;
Yu, Tian;
Constance, Jonathan E.;
Moorthy, Ganesh;
Spigarelli, Michael G.;
Desai, Pankaj B.;
Sherwin, Catherine M. T.

Publication type:

Article

Pipe Dreams About Apixaban for Stroke Prevention in Renal Impairment.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 5, p. 646, doi. 10.1002/jcph.656

By:

Stöllberger, Claudia;
Finsterer, Josef

Publication type:

Article